Your browser doesn't support javascript.

Portal de Pesquisa da BVS

Informação e Conhecimento para a Saúde

Home > Pesquisa > (6.250)

Filtros selecionados

  • Base de dados
    • CDSR - Revisões sistemáticas Cochrane (remover)
Detalhe da pesquisa
Imprimir Exportar

Formato de exportação:



Exportar:

Email
Adicionar mais destinatários

Esta página Sua seleção Todas as referências (max. 300)
|
Resultados 1 - 10 de 6.250
1.

Multidisciplinary rehabilitation after primary brain tumour treatment / Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours / Factors affecting recovery after acoustic neuroma resection / Comparison of functional outcomes in low- and high-grade astrocytoma rehabilitation inpatients / Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial / Functional recovery of patients with brain tumor or acute stroke after rehabilitation: a comparative study / Rehabilitation outcomes in patients with brain tumors and acute stroke: comparative study of inpatient rehabilitation / Functional outcome after brain tumor and acute stroke: a comparative analysis / Functional outcomes in patients with brain tumor after inpatient rehabilitation: comparison with traumatic brain injury / Functional outcomes and quality of life in patients with brain tumors: a preliminary report / Addition of intensive repetition of facilitation exercise to multidisciplinary rehabilitation promotes motor functional recovery of the hemiplegic lower limb / Functional outcomes following rehabilitation of the cancer patients / Functional outcomes of persons with brain tumors after inpatient rehabilitation. / Functional outcome of inpatient rehabilitation in persons with brain tumors / Home rehabilitation for brain tumor patients. / Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: A randomized controlled trial / Efficacy of postacute brain Injury rehabilitation for patients with primary malignant brain tumors / Rehabilitation in primary and metastatic brain tumours: impact of functional outcomes on survival / The effect of early customized vestibular rehabilitation on balance after acoustic neuroma resection / Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial / A study of patients with a primary malignant brain tumour and their carers: symptoms and access to services / AROC Inpatient Clinical Data Set. / Trends and advances in cancer survivorship research: challenge and opportunity / Braintumor rehabilitation: survey of clinical practice (Abstract) / Brain tumour and brain cancer, Australia / Secondary health conditions among middle aged individuals with chronic physical disabilities: implications for unmet needs for services / Cancer Reform Strategy / The International Classification of Functioning Disability and Health: its development process and content validity / Cancer Survivorship Briefing Paper / Rehabilitation of the cancer patient / Bias in location and selection of studies / Measuring the functional impact of fatigue: initial validation of the fatigue impact scale / Brain tumors in the older person / Cancer rehabilitation: challenges, approaches, and new directions / A rehabilitative approach to the patient with brain cancer / The CARES: a generic measure of health related quality of life for patients with cancer / Development of a work instability scale for rheumatoid arthritis / Reference bias in reports of drug trials / The emerging science of functional assessment: our tool for outcomes analysis / Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 / Breast cancer survivors supportive care needs 2-10 years after diagnosis / Functional outcomes and quality of life in patients with brain tumours: a review of the literature / Inpatients rehabilitation of patients with cancer: efficacy and treatment consideration / Cancer statistics / Multiple Sclerosis Rehabilitation Outcomes: Analysis of a National Casemix Dataset from Australia / Multidisciplinary care for Guillain-Barre Syndrome / Multidisciplinary rehabilitation for adults with multiple sclerosis / Rehabilitation of persons with central nervous system tumors / Perspective of physicians within a multidisciplinary team: Content validation of the comprehensive ICF core set for head and neck cancer / The 2007 WHO classification of tumours of the central nervous system / Promoting functional capacity of cancer patients / Effects of aerobic interval training on cancer patients functional capacity / Functional evaluation: the Barthel Index / Exercise for women receiving adjuvant therapy for breast cancer / Exercise interventions for upper-limb dysfunction due to breast cancer treatment / A framework for development and evaluation of RCTs for complex interventions to improve health / National Coalition for Cancer Survivorship / Physical performance limitations among adult survivors of childhood brain tumors / A biopsychosocial perspective on adjustment and quality of life following brain tumor: a systematic evaluation of the literature / Functional outcome of inpatient rehabilitation in persons with brain tumors / Measuring the impact and distress of health problems from the individual's perspective: development of the Perceived Impact of Problem Profile (PIPP) / Cancer incidence in five continents, vol. I to VIII / Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases / Psychological intervention in young brain tumor survivors: the efficacy of the cognitive behavioural approach / Review Manager (RevMan) / Cancer rehabilitation evaluation system-short form (CARES-SF) / The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta analyses / Predictors of distress in caregivers of persons with a primary malignant brain tumor / Chemotherapy for high-grade glioma / Organised inpatient (stroke unit) care for stroke / Development of ICF core sets for head and neck cancer / Content validation of the international classification of functioning, disability and health core sets for head and neck cancer: a multicentre study / The health of women with cerebral palsy / Multidisciplinary rehabilitation for acquired brain injury in adults of working age / Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group / Brain tumor rehabilitation

Khan Fary, Amatya Bhasker, Ng Louisa, Drummond Kate, Olver John; Bartolo M; Zucchella C; Pace A; Lanzetta G; Vecchione C; Bartolo M; Cohen HS; Kimball KT; Jenkins HA; Fu JB; Parsons HA; Shin KY; Guo Y; Konzen BS; Yadav RR; Gehring K; Sitskoorn MM; Gundy CM; Sikkes SAM; Klein M; Postma TJ; Geler-Kulcu D; Gulsen G; Buyukbaba E; Ozkan D; Greenberg E; Treger I; Ring H; Huang ME; Cifu DX; Keyser-Marcus L; Huang ME; Cifu DX; Keyser-Marcus L; Huang ME; Wartella JE; Kreutzer JS; Kawahira K; Shimodozono M; Ogata A; Tanaka N; Marciniak CM; Sliwa JA; Spill G; Heinemann AW; Semik PE; Marciniak CM; Sliwa JA; Heinemann AW; Semik PE; O'Dell MW; Barr K; Spanier D; Warnick RE; Pace A; Parisi C; Lelio M; Zizzari A; Petreri G; Giovannelli M; Rummans TA; Clark MM; Sloan JA; Frost MH; Bostwick JM; Atherton PJ; Sherer M; Meyers CA; Bergloff P; Tang V; Rathbone M; Park Dorsay J; Jiang S; Harvey D; Vereeck L; Wuyts FL; Truijen S; Valck C; Heyning PH; Andrews DW; Scott CB; Sperduto PW; Flanders AE; Gaspar LE; Schell MC; Arber A; Faithfull S; Plaskota M; Lucas C; Vries K; Aziz NM; Rowland JH; Boake C; Meyers CA; Campbell ML; Sheets D; Strong PS; Cieza A; Stucki G; Corner J; Richardson A; Dietz JH; Egger M; Smith GD; Fisk JD; Ritvo PG; Ross L; Haase DA; Marrie TJ; Schlech WF; Flowers A; Franklin DJ; Gabanelli P; Ganz PA; Schag CA; Lee TJ; Sims MS; Gilworth G; Chamberlain MA; Harvey A; Goetzsche PC; Granger CV; Higgins JPT; Green S (editors); Hodgkinson K; Butow P; Hunt G; Pendlebury S; Hobbs K; Wain G; Huang ME; Wartella J; Kreutzer J; Broaddus W; Lyckholm L; Huang ME; Silwa JA; Jemal A; Siegel R; Ward E; Hao Y; Xu J; Thun MJ; Khan F; Turner Stokes L; Stevermuer T; Simmonds F; Khan F; Ng L; Amatya B; Brand C; Turner-Stokes L; Khan F; Turner-Stokes L; Ng L; Kilpatrick T; Amatya B; Kirshblum S; O'Dell MW; Ho C; Barr K; Leib A; Cieza A; Tschiesner U; Louis DN; Ohgaki H; Wiestler OD; Cavenee WK; Burger PC; Jouvet A; Lovibond SH; Lovibond PF; MacVicar MG; Winningham ML; MacVicar MG; Winningham ML; Nickel JL; Mahoney FI; Barthel D; Markes M; Brockow T; Resch KL; McNeely ML; Campbell K; Opsina M; Rowe BH; Dabbs K; Klassen TP; NCCS; Ness KK; Morris EB; Nolan VG; Howell CR; Gilchrist LS; Stovall M; Ownsworth T; Hawkes A; Steginga S; Walker D; Shum D; O’Dell MW; Barr K; Spanier D; Warnick RE; Pallant JF; Misajon R; Bennett E; Manderson L; Parkin DM; Whelan SL; Ferlay J; Pirzkall A; Debus J; Lohr F; Fuss M; Rhein B; Engenhart-Cabillic R; Poggi G; Liscio M; Pastore V; Adduci A; Galbiati S; Spreafico F; Schag CA; Ganz PA; Heinrich RL; Sheard T; Maguire P; Sherwood PR; Given BA; Given CW; Schiffman RF; Murman DL; Lovely M; Stewart L; Burdett S; Tschiesner U; Rogers S; Dietz A; Yueh B; Cieza A; Tschiesner U; Linseisen E; Becker S; Mast G; Rogers SN; Walvekar RR; Turk MA; Scandale J; Rosenbaum PF; Weber RJ; Turner Stokes L; Nair A; Sedki I; Disler PB; Wade DT; Tulder MW; Furlan A; Bombardier C; Bouter L; Vargo M; Wade DT; Ware JE; Snow KK; Kosinski M; Gandek B.
| CDSR - Revisões sistemáticas Cochrane | ID: CD009509
2.

Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion / Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study / Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study / Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion / Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator / Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes / Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion / Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1) / Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion / Treatment of branch retinal vein occlusion induced macular edema with bevacizumab / The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion / Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins / Hypoxic regulation of vascular endothelial growth factor in retinal cells / Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire / Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion / Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group / Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema / Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion / Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study / A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion / Treatment of branch retinal vein occlusion induced macular edema in treatment-naive cases with a single intravitreal triamcinolone or bevacizumab injection / Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion / Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion / Chapter 9: Analysing data and undertaking meta-analyses / Retinal vein occlusion and the prevalence of lipoprotein abnormalities / Diabetes mellitus and retinal vein occlusion in patients of Asian, West Indian and white European origin / Risk factors for branch retinal vein occlusion. The Eye Disease Case-Control Study Group / Retinal vein occlusion: beyond the acute event / Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration / Results of bevacizumab as the primary treatment for retinal vein occlusions / Histopathologic study of nine branch retinal vein occlusions / Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab / Ranibizumab: in macular oedema following retinal vein occlusion / Prognostic factors for retinal vein occlusion: prospective study of 175 cases / How to identify randomized controlled trials in MEDLINE: ten years on / Pegaptanib for neovascular age-related macular degeneration / Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion / Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion / Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion / Effect of repeated intravitreal bevacizumab injections for secondary macular edema of branch retinal vein occlusion / Chapter 8: Assessing risk of bias in included studies / Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion / Intravitreal bevacizumab versus triamcinolone acetonide for macular edema due to branch retinal vein occlusion: a matched study / Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion / One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion / Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion / The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study / The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study / Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion:results after 12 months and multiple regression analysis / Ranibizumab for the treatment of neovascular age-related macular degeneration: a review / Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion / Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study / Interventions for branch retinal vein occlusion: an evidence-based systematic review / Early Avastin management in acute retinal vein occlusion / Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study / A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab / Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion / Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates / Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion / Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up / Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial / Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders / Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion / Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities / Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion / Review Manager (RevMan). Version 5.1 / Natural history of branch retinal vein occlusion: an evidence-based systematic review / The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia / Ranibizumab for neovascular age-related macular degeneration / Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study / Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion / A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6 / New vessel formation in retinal branch vein occlusion / Bevacizumab in retinal vein occlusion-results of a prospective case series / Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies / Retinal vein occlusions and mortality: the Beijing Eye Study / Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study

Mitry Danny, Bunce Catey, Charteris David; Brown DM; Campochiaro PA; Bhisitkul RB; Ho AC; Gray S; Saroj N; Campochiaro PA; Heier JS; Feiner L; Gray S; Saroj N; Rundle AC; Russo V; Barone A; Conte E; Prascina F; Stella A; Noci ND; Campochiaro PA; Hafiz G; Shah SM; Nguyen QD; Ying H; Do DV; Campochiaro PA; Hafiz G; Channa R; Shah SM; Nguyen QD; Ying H; Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C; Moradian S; Faghihi H; Sadeghi B; Piri N; Ahmadieh H; Soheilian M; Wroblewski JJ; Wells JA; Gonzales CR; Abegg M; Tappeiner C; Wolf-Schnurrbusch U; Barthelmes D; Wolf S; Fleischhauer J; Ahmadi AA; Chuo JY; Banashkevich A; Ma PE; Maberley DA; Aiello LP; Pierce EA; Foley ED; Takagi H; Chen H; Riddle L; Aiello LP; Northrup JM; Keyt BA; Takagi H; Iwamoto MA; Awdeh RM; Elsing SH; Deramo VA; Stinnett S; Lee PP; Fekrat S; Boyd SR; Zachary I; Chakravarthy U; Allen GJ; Wisdom GB; Cree IA; Anonymous; Byeon SH; Kwon YA; Oh HS; Kim M; Kwon OW; Byun YJ; Roh MI; Lee SC; Koh HJ; Campochiaro PA; Heier JS; Feiner L; Gray S; Saroj N; Rundle AC; Cekic O; Cakir M; Yazici AT; Alagoz N; Bozkurt E; Faruk Yilmaz O; Chen CH; Chen YH; Wu PC; Chen YJ; Lee JJ; Liu YC; Cheng KC; Wu WC; Chen KJ; Chung EJ; Hong YT; Lee SC; Kwon OW; Koh HJ; Deeks JJ; Higgins JPT; Altman DG (editors); Dodson PM; Galton DJ; Hamilton AM; Blach RK; Dodson PM; Kritzinger EE; Clough CG; Anonymous; Ehlers JP; Fekrat S; Ferrara N; Damico L; Shams N; Lowman H; Kim R; Figueroa MS; Contreras I; Noval S; Arruabarrena C; Frangieh GT; Green WR; Barraquer-Somers E; Finkelstein D; Funk M; Kriechbaum K; Prager F; Benesch T; Georgopoulos M; Zlabinger GJ; Garnock-Jones KP; Glacet-Bernard A; Coscas G; Chabanel A; Zourdani A; Lelong F; Samama MM; Glanville JM; Lefebvre C; Miles JN; Camosso-Stefinovic J; Gragoudas ES; Adamis AP; Cunningham ET; Feinsod M; Guyer DR; Gregori NZ; Rattan GH; Rosenfeld PJ; Puliafito CA; Feuer W; Flynn HW; Gunduz K; Bakri SJ; Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Hara S; Sakuraba T; Kataoka H; Yanagihashi S; Saitou K; Noda Y; Higgins JPT; Altman DG; Sterne JAC (editors); Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S; Hou J; Tao Y; Jiang YR; Li XX; Gao L; Hung KH; Lee SM; Lee SY; Lee FL; Yang CS; Jaissle GB; Leitritz M; Gelisken F; Ziemssen F; Bartz-Schmidt KU; Szurman P; Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Klein R; Klein BE; Moss SE; Meuer SM; Klein R; Moss SE; Meuer SM; Klein BE; Kondo M; Kondo N; Ito Y; Kachi S; Kikuchi M; Yasuma TR; Kourlas H; Abrams P; Kreutzer TC; Alge CS; Wolf AH; Kook D; Burger J; Strauss R; Kriechbaum K; Michels S; Prager F; Georgopoulos M; Funk M; Geitzenauer W; McIntosh RL; Mohamed Q; Saw SM; Wong TY; Mehany SA; Mitchell P; Smith W; Chang A; Mitchell P; Noma H; Minamoto A; Funatsu H; Tsukamoto H; Nakano K; Yamashita H; Ozaki H; Hayashi H; Vinores SA; Moromizato Y; Campochiaro PA; Oshima K; Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Pece A; Isola V; Piermarocchi S; Calori G; Prager F; Michels S; Kriechbaum K; Georgopoulos M; Funk M; Geitzenauer W; Presta LG; Chen H; O'Connor SJ; Chisholm V; Meng YG; Krummen L; Rabena MD; Pieramici DJ; Castellarin AA; Nasir MA; Avery RL; Rehak J; Rehak M; Rensch F; Jonas JB; Spandau UH; Rogers SL; McIntosh RL; Lim L; Mitchell P; Cheung N; Kowalski JW; Rogers S; McIntosh RL; Cheung N; Lim L; Wang JJ; Mitchell P; Rosenfeld PJ; Brown DM; Heier JS; Boyer DS; Kaiser PK; Chung CY; Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I; Schaal KB; Hoh AE; Scheuerle A; Schutt F; Dithmar S; Scott IU; Ip MS; VanVeldhuisen PC; Oden NL; Blodi BA; Fisher M; Shilling JS; Kohner EM; Stahl A; Agostini H; Hansen LL; Feltgen N; Wong TY; Larsen EK; Klein R; Mitchell P; Couper DJ; Klein BE; Xu L; Liu WW; Wang YX; Yang H; Jonas JB; Yasuda M; Kiyohara Y; Arakawa S; Hata Y; Yonemoto K; Doi Y.
| CDSR - Revisões sistemáticas Cochrane | ID: CD009510
3.

Interventions to improve adherence to antiretroviral therapy in children with HIV infection / Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention / Evaluation of a peer support group therapy for HIV-infected adolescents / Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy / Medication diaries do not improve outcomes with highly active antiretroviral therapy in Kenyan children: a randomized clinical trial / Use of taste-masking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals / Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time / Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti-HIV/AIDS liquid formulations with improved patient compliance / Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study / Use of multisystemic therapy to improve antiretroviral adherence and health outcomes in HIV-infected pediatric patients: evaluation of a pilot program / Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS / Short course directly observed therapy to monitor compliance with antiretroviral therapy in human immunodeficiency virus-infected children / Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications / A comprehensive programme to strengthen adherence to antiretroviral drug therapy and achieve virological control in HIV infected children in Thailand / Parmacokinetics and tolerability of once- versus twice-daily lopinavir/ritonavir treatment in HIV-1-infected children / Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules / A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project / Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021 / Directly observed highly active antiretroviral therapy fo HIV-infected children in Cambodia / Healthy choices: motivational enhancement therapy for health risk behaviors in HIV-positive youth / Brief report: Maintenance of effects of motivational enhancement therapy to improve risk behaviors and HIV-related health in a randomized controlled trial of youth living with HIV / Improving health outcomes for youth living with the human immunodeficiency virus: A multisite randomized trial of a motivational intervention targeting multiple risk behaviors / A multisite randomized trial of a motivational intervention targeting multiple risks in youth living with HIV: initial effects on motivation, self-efficacy, and depression / Multidisciplinary, inpatient directly observed therapy for HIV-1-infected children and adolescents failing HAART: a retrospective study / The use of cell phone reminder calls for assisting HIV-infected adolescents and young adults to adhere to highly active antiretroviral therapy: a pilot study / Virologic response using directly observed therapy in adolescents with HIV: an adherence tool / A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth / Compliance aids: do they work? / Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect / The TREAT (Therapeutic Regimens Enhancing Adherence in Teens) Program: theory and preliminary results / Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression / Adherence to high activity antiretroviral therapy (HAART) in pediatric patients infected with HIV: issues and interventions / Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus / Antiretroviral adherence interventions: a review of current literature and ongoing studies / Adherence to antiretroviral therapy for pediatric HIV infection: A qualitative systematic review with recommendations for research and clinical management / Gastrostomy tube placement in nonadherent HIV-infected children / Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care / Implementation of a comprehensive program including psycho-social and treatment literacy activities to improve adherence to HIV care and treatment for a pediatric population in Kenya / HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand. / Non-adherence to highly active antiretroviral therapy predicts progression to AIDS / Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents / Directly observed antiretroviral therapy: A systematic review and meta-analysis of randomised clinical trials / Pediatric adherence to HIV antiretroviral therapy / Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy / Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: A meta-analysis and systematic review / Increasing antiretroviral drug access for children with HIV infection / Interventions for enhancing medication adherence / Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up / Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic / Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA / Long-Term Effectiveness of Highly Active Antiretroviral Therapy on the Survival of Children and Adolescents with HIV Infection: A 10-Year Follow-Up Study / Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy / Adherence to medication regimens among children with human immunodeficiency virus infection / A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth / Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children / Adherence to antiretroviral therapy for pediatric HIV infection: A qualitative systematic review with recommendations for research and clinical management / Adherence to antiretroviral therapy for pediatric HIV infection: Review of the literature and recommendations for research / Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection / A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries / Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1

Bain-Brickley Deborah, Butler Lisa M, Kennedy Gail E, Rutherford George W; Berrien VM; Salazar JC; Reynolds E; McKay K; Funck-Brentano I; Dalban C; Veber F; Quartier P; Hefez S; Costagliola D; Blanche S; Muller AD; Myer L; Jaspan H; Wamalwa DC; Farquhar C; Obimbo EM; Selig S; Mbori-Ngacha DA; Richardson BA; Overbaugh J; Egondi T; Inwani I; John-Stewart G; Bunupuradah T; Wannachai S; Chuamchaitrakool A; Intasan J; Nuchapong T; Neiss W; Kramm K; Pancharoen C; Burger D; Ananworanich J; Byakika-Tusiime J; Crane J; Oyugi JH; Ragland K; Kawuma A; Musoke P; Bangsberg DR; Chiappetta DA; Carcaboso AM; Bregni C; Rubio M; Bramuglia G; Sosnik A; Davies MA; Boulle A; Fakir T; Nuttall J; Eley B; Ellis DA; Naar-King S; Cunningham PB; Secord E; Garvie PA; Lensing S; Rai SN; Gigliotti F; Murante BL; Weinberg GA; Glikman D; Walsh L; Valkenburg J; Mangat D; Marcinak JF; Hansudewechakul R; Jourdain G; Plangraun N; Porte C; Heeswijk R; Mitchell CD; Zhang G; Parker J; Rongkavilit C; Roux SM; Cotton MF; Golub JE; Roux DM; Workman L; Zar HJ; Lyon ME; Trexler C; Akpan-Townsend C; Pao M; Selden K; Fletcher J; Addlestone IC; D'Angelo LJ; McKinney RE; Rodman J; Hu C; Britto P; Hughes M; Smith ME; Serchuck LK; Kraimer J; Ortiz AA; Flynn P; Yogev R; Spector S; Draper L; Tran P; Scites M; Dickover R; Weinberg A; Cunningham C; Abrams E; Blum MR; Chittick GE Reynolds L; Rathore M; Myung P; Pugatch D; Brady MF; Many P; Harwell JI; Lurie M; Tucker J; Naar-King S; Wright K; Parsons JT; Frey M; Templin T; Lam P; Murphy D; Naar-King S; Lam P; Wang B; Wright K; Parsons JT; Frey MA; Naar-King S; Parsons JT; Murphy DA; Chen X; Harris R; Belzer ME; Naar-King S; Parsons JT; Murphy D; Kolmodin K; Harris DR; Parsons GN; Siberry GK; Parsons JK; Christensen JR; Joyner ML; Lee SL; Kiefner CM; Hutton N; Puccio JA; Belzer M; Olson J; Martinez M; Salata C; Tucker D; Tanaka D; Purdy JB; Freeman AF; Martin SC; Ryder C; Elliott-DeSorbo DK; Zeichner S; Hazra R; Reisner SL; Mimiaga MJ; Skeer M; Perkovich B; Johnson CV; Safren SA; Rivers PH; Roberts GM; Wheeler JG; Tucker NC; Hackler C; Young K; Maples HD; Darville T; Rogers AS; Miller S; Murphy DA; Tanney M; Fortune T; Rudy BJ; Sleasman J; Kapogiannis B; Wilson CM; Bethel J; Serchuck L; Ahmad S; Cunningham CK; Shah CA; Shingadia D; Viani RM; Yogev R; Binns H; Dankner WM; Spector SA; Chadwick EG; Simoni JM; Frick PA; Pantalone DW; Turner BJ; Simoni JM; Montgomery A; Martin E; New M; Demas PA; Rana S; Temple ME; Koranyi KI; Nahata MC; Griensven J; Naeyer L; Uwera J; Asiimwe A; Gazille C; Reid T; Winghem J; Telfer B; Reid T; Ouko J; Mutunga A; Jama Z; Vakil S; Wilson D; Keiluhu AK; Kogrum S; Reid T; Seriratana N; Ford N; Kyawkyaw M; Talangsri P; Taochalee N; Bangsberg DR; Perry S; Charlebois ED; Clark RA; Roberston M; Zolopa AR; Moss A; Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G; Ford N; Nachega JB; Engel ME; Mills EJ; Haberer J; Mellins C; Harrigan PR; Hogg RS; Dong WW; Yip B; Wynhoven B; Woodward J; Brumme CJ; Brumme ZL; Mo T; Alexander CS; Montaner JS; Hart JE; Jeon CY; Ivers LC; Behforouz HL; Caldas A; Drobac PC; Shin SS; Havens PL; Gibb DM; Haynes RB; Ackloo E; Sahota N; McDonald HP; Yao X; Higgins JPT; Green S (editors); Hogg RS; Heath K; Bangsberg D; Yip B; Press N; O'Shaughnessy MV; Montaner JS; Martinez J; Bell D; Camacho R; Henry-Reid LM; Bell M; Watson C; Rodriguez F; Murphy DA; Wilson CM; Durako SJ; Muenz LR; Belzer M; Patel K; Hernan MA; Williams PL; Seeger JD; McIntosh K; Dyke RB; Seage Iii GR; Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjananit S; Wannarit P; Sirisanthana T; Sirisanthana V; Reddington C; Cohen J; Baldillo A; Toye M; Smith D; Kneut C; Demaria A; Bertolli J; Hsu HW; Reisner SL; Mimiaga MJ; Skeer M; Perkovich B; Johnson CV; Safren SA; Resino S; Resino R; Maria Bellon J; Micheloud D; Gutierrez MD; Jose MI; Ramos JT; Fontelos PM; Ciria L; Munoz-Fernandez MA; Simoni JM; Montgomery A; Martin E; New M; Demas PA; Rana S; Steele RG; Grauer D; UNAIDS; Dyke RB; Lee S; Johnson GM; Wiznia A; Mohan K; Stanley K; Morse EV; Krogstad PA; Nachman S; Vreeman RC; Wiehe SE; Pearce EC; Nyandiko WM; Watson DC; Farley JJ.
| CDSR - Revisões sistemáticas Cochrane | ID: CD009513
4.

Relaxation techniques for pain management in labour / The use of respiration and relaxation techniques for pain and anxiety relief in the parturition process / Effect of progressive muscle relaxation technique on pain relief during labor / Effects of natural childbirth preparation versus standard antenatal education on epidural rates, experience of childbirth and parental stress in mothers and fathers: a randomised controlled multicentre trial / Effects of natural childbirth preparation versus standard antenatal education on epidural rates, experience of childbirth and parental stress in mothers and fathers: a randomised controlled multicentre trial / Yoga during pregnancy: effects on maternal comfort, labor pain and birth outcomes / The effect of music as a conditioning aid in prepared childbirth education / Obstetric psychophysiology and quality of the experience of labour/delivery: application within hospitals / Effects of music therapy on labour pain and anxiety in Taiwanese first time mothers / Clinical trial of audio analgesia in childbirth / The effects of the PSU Cat position and music on length of time in the active phase of labor and labor pain / The effect of breathing and skin stimulation on labour pain perception of Turkish women / The effects of breathing and tactile stimulation techniques on the pain perception of pregnants during labour / The effect of antenatal education interventions on state-trait anxiety in the parturition process / Does relaxation education in anxious Iranian women influence adverse pregnancy outcomes? / Using music during childbirth / Maternal respiration in labour / Effects of music and imagery on physiologic and self report of analogues labour pain / Clinical study on shortening birth process by psychological suggestion therapy / Music reduces sensation and distress of labor pain / Effects of music therapy on anxiety levels and pain perception / Comfortable nursing and the mental state in parturient women / The use of music by women during childbirth / The effect of guided imagery on the third stage of labor: a pilot study / The effect of antenatal education on pain intensity and labor / Women's use of complementary and alternative medicine during pregnancy: a critical review of the literature / Epidural versus non-epidural or no analgesia in labour / Complementary and alternative medicine use among adults: United States, 2002 / Biofeedback for pain management during labour / Immersion in water in labour and birth / Intracutaneous or subcutaneous sterile water injection for relieving pain in labour / Transcutaneous electrical nerve stimulation (TENS) for pain relief in labour / Bias in meta-analysis detected by a simple, graphical test / Trends in alternative medicine use in the United States, 1990-1997: results of a follow up national survey / Introduction to yoga / A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints / Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 / Pain management for women in labour: generic protocol / Pain management for women in labour: an overview of systematic reviews / Inhaled analgesia for pain management in labour / Working with pain in labour: an overview of evidence / Hypnosis for pain management during labour and childbirth / Cochrane Complementary Medicine Field / The myth of painless childbirth / Pain and neuromatrix in the brain / Analgesia and satisfaction in childbirth (the Queen Charlotte's 1000 mother survey) / Local anaesthetic nerve block for pain management in labour / Non-opioid drugs for pain management in labour / Review Manager (RevMan) / Chronic pain: a reformulation of the cognitive-behavioural model / Combined spinal-epidural versus epidural analgesia in labour / Acupuncture or acupressure for pain management in labour / Aromatherapy for pain management in labour / Manual healing methods including massage and reflexology for pain management in labour / The neuromatrix theory of pain: implications for selected non-pharmacological methods of pain relief for labor / Parenteral opioids for maternal pain relief in labour / ABC of complementary medicine: hypnosis and relaxation therapies / Cognitive modulation of pain: how do attention and emotion influence pain processing? / Complementary and alternative therapies for pain management in labour

Smith Caroline A, Levett Kate M, Collins Carmel T, Crowther Caroline A; Almeida NA; Sousa JT; Bachion MM; Silveira NA; Bagharpoosh M; Sangestani G; Goodarzi M; Bergstrom M; Kieler H; Waldenstrom U; Bergstrom M; Kieler H; Waldenstrom U; Chuntharapat S; Petpichetchian W; Hatthakit U; Durham L; Collins M; Gatelli L; Panzeri M; Casadei D; Pagan F; Liu YH; Chang MY; Chen CH; Moore WMO; Browne JCM; Phumdoung S; Youngvanichsate S; Jongpaiboonpatana W; Leetanaporn R; Yildirim G; Sahin NH; Yildirim G; Sahin NH; Ahmadian heris S; Taghavi S; Hoseininasab D; Bastani F; Hidarnia A; Montgomery KS; Aguilar-Vafaei ME; Kazemnejad A; Browning CA; Buxton R St J; Geden E; Lower M; Beattie S; Beck N; Hao TY; Li YH; Yao SF; Phumdoung S; Good M; Podder L; Ran KQ; He AM; Han QR; Tang ZL; Lei FH; Sammons LN; Schorn MN; Taghavi S; Hoseininasab D; Ahmadian heris S; Adams J; Lui C-W; Sibbritt D; Broom A; Wardle J; Homer C; Anim-Somuah M; Smyth R; Howell CJ; Barnes PM; Powell-Griner E; McFann K; Nahin RL; Barragán LIM; Solà I; Juandó PC; Bennett VR; Brown LK; Cluett ER; Burns E; Derry S; Straube S; Moore RA; Hancock H; Collins SL; Dick Read G; Dowswell T; Bedwell C; Lavender T; Neilson JP; Egger M; Davey Smith G; Schneider M; Minder C; Eisenberg DA; Davis RB; Ettner SL; Appel S; Wilky S; Rompay M; Fisher L; Harbord RM; Egger M; Sterne JA; Higgins JPT; Green S; Jacobson E; Jones L; Dou L; Dowswell T; Alfirevic Z; Neilson James P; Jones L; Othman M; Dowswell T; Alfirevic Z; Gates S; Newburn M; Klomp T; Poppel M; Lazet J; Nisio M; Leap N; Dodwell M; Newburn M; Madden K; Middleton P; Cyna AM; Matthewson M; Manheimer E; Berman B; McCaffery M; Melzack R; Melzack R; Morgan BM; Bulpitt CJ; Clifton P; Lewis PJ; Novikova N; Cluver C; Othman M; Jones L; Neilson James P; Sharp TJ; Simmons S; Cyna AM; Dennis AT; Hughes D; Smith CA; Collins CT; Crowther CA; Levett KM; Smith CA; Collins CT; Crowther CA; Smith CA; Levett KM; Collins CT; Jones L; Trout KK; Ullman R; Smith LA; Burns E; Mori R; Dowswell T; Velvovsky IPK; Ploticher V; Shugom E; Vickers A; Zolloman C; Villemure CM; Bushnell MC; Smith CA; Collins CT; Cyna AM; Crowther CA.
| CDSR - Revisões sistemáticas Cochrane | ID: CD009514
5.

Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery / Optimal timing of prophylactic antibiotic for cesarean delivery: a randomized comparative study / Timing of prophylactic antibiotic at cesarean section: A double-blinded, randomized trial / Comparison of administration of single dose ceftriaxone for elective caesarean section before skin incision and after cord clamping in preventing post-operative infectious morbidity / Antibiotic prophylaxis at elective cesarean section: a randomized controlled trial in a low resource setting / Timing of antibiotic prophylaxis at cesarean- results of an RCT / The timing of antibiotics at cesarean: A randomized controlled trial / Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesarean infectious morbidity / Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesarean infectious morbidity: a randomized, controlled trial / Timing of prophylactic antibiotic administration in the uninfected laboring gravida: a randomized clinical trial / Single dose cefazolin prophylaxis for postcesarean infections: before vs after cord clamping / Antibiotic prophylaxis before surgery vs after cord clamping in elective cesarean delivery: a double-blind, prospective, randomized, placebo-controlled trial / When should we perform prophylactic antibiotics in elective cesarean cases? / Perioperative antimicrobials for cesarean delivery: before or after cord clamping? / Identification and management of women at high risk for pelvic infection following cesarean section / Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping / The comparison of piperacillin use for prophylaxis of post cesarean section infection before and after clamping umbilical cord [abstract] / Timing of prophylactic antibiotic administration in term cesarean section: a randomized clinical trial / Ceftazidime in antibiotic prophylaxis for emergency cesarean section: a randomized prospective study / Prevention of post-caesarean infections in low resource countries: is a single dose as adequate as a multiple dose antibiotic regiment? A randomised controlled trial / Comparison of a single prophylactic dose of ampicillin and metronidazole before caesarean section with a multiple day regimen of these antibiotics in prevention of postpartum maternal infection in a low resource setting: a randomized controlled trial / Use of cefotaxime to control post-operative infection in patients who underwent C-section / Antimicrobial prophylaxis for cesarean delivery: timing of administration. Committee Opinion No. 465 / Timing of administration of prophylactic antibiotics for caesarean section: a systematic review and meta-analysis / Reduction of surgical site infections after Cesarean delivery using surveillance / Timing of prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery / Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? / Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project / The effective period of preventive antibiotic action in experimental incisions and dermal lesions / The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection / Timing of perioperative antibiotics for cesarean delivery: a metaanalysis / Evidence-based surgery for cesarean delivery: an updated systematic review / Uterine exteriorization at cesarean section: influence on maternal morbidity / Maternal and transplacental pharmacokinetics of cefazolin / Inequities in the use of cesarean section deliveries in the world / GRADEpro / Prophylactic subcutaneous drainage for prevention of wound complications after cesarean delivery--a metaanalysis / Incidence of hospital-acquired infections associated with cesarean section / Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated September 2011]. The Cochrane Collaboration, 2011 / Antibiotic prophylaxis regimens and drugs for cesarean section / Effect of a change in policy regarding the timing of prophylactic antibiotics on the rate of postcesarean delivery surgical-site infections / Risk of selected postpartum infections after cesarean section compared with vaginal birth: a five-year cohort study of 32,468 women / Skin preparation methods before cesarean section. A comparative study / Preoperative skin preparation and intraoperative pelvic irrigation: impact on post-cesarean endometritis and wound infection / Guideline for prevention of surgical site infection, 1999: Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee / National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 / Risk factors for surgical site infection after low transverse cesarean section / Post-cesarean surgical site infections according to CDC standards: rates and risk factors. A prospective cohort study / Antimicrobial prophylaxis for cesarean delivery before skin incision / Review Manager (RevMan) / GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice [GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen] / Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010 / Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section / Surgical safety checklists / Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study / Preoperative vaginal preparation with povidone-iodine and the risk of postcesarean endometritis / Decreasing infectious morbidity in cesarean delivery by changing gloves / Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study / Epidemiology of and surveillance for postpartum infections

Mackeen A. Dhanya, Packard Roger E, Ota Erika, Berghella Vincenzo, Baxter Jason K; Bhattacharjee N; Saha SP; Patra KK; Mitra U; Ghoshroy SC; Francis C; Mumford M; Strand ML; Moore ES; Strand EA; Kalaranjini S; Veena P; Rani R; Kandil M; Sanad Z; Gaber W; Macones G; Cleary K; Odibo A; Gross G; Parry S; Rampersad R; Macones GA; Cleary KL; Parry S; Stamilio DM; Cahill AG; Odibo AO; Sullivan S; Smith T; Chang E; Hulsey T; Dorsten J; Soper D; Sullivan SA; Smith T; Chang E; Hulsey T; Vandorsten JP; Soper D; Thigpen BD; Hood WA; Chauhan S; Bufkin L; Bofill J; Magann E; Wax JR; Hersey K; Philput C; Wright MS; Nichols KV; Eggleston MK; Witt A; Doner M; Petricevic L; Berger A; Germann P; Heinze G; Yildirim G; Gungorduk K; Guven HZ; Aslan H; Celikkol O; Sudolmus S; Cunningham FG; Leveno KJ; Palma RT; Roark ML; Rosenfeld CR; Palma RT; Leveno KJ; Cunningham FG; Pope T; Kappus SS; Roark ML; Gordon HR; Phelps D; Blanchard K; Gul A; Zeteroilu I; Surucu R; Nokiani FA; Akbari H; Rezaei M; Tassi PG; Tarantini M; Cadenelli GP; Gastaldi A; Benedetti M; Beekhuizen H; Velzen C; Kolk P; Westen E; Mmuni N; Hamisi A; Nakua R; Xu X; Zhang W; He X; Baaqeel H; Baaqeel R; Barwolff S; Sohr D; Feffers C; Brandt C; Vonberg RP; Halle H; Baxter JK; Berghella V; Mackeen AD; Ohly NT; Weed S; Bloom SL; Cox SM; Bawdon RE; Gilstrap LC; Bratzler DW; Houck PM; Burke JF; Classen DC; Evans RS; Pestotnik SL; Horn SD; Menlove RL; Burke JP; Costantine MM; Rahman M; Ghulmiyah L; Byers BD; Longo M; Wen T; Dahlke J; Mendez-Figueroa H; Rouse D; Berghella V; Baxter J; Chauhan; S; Edi-Osagie EC; Hopkins RE; Ogbo V; Lockhat-Cleff F; Ayeko M; Akpala WO; Fiore Mitchell T; Pearlman MD; Chapman RL; Bhatt-Mehta V; Faiz RG; Gibbons L; Belizan JM; Lauer JA; Betran AP; Merialdi M; Althabe F; Jan Brozek; Andrew Oxman; Holger Schünemann; Hellums EK; Lin MG; Ramsey PS; Henderson E; Love EJ; Higgins JPT; Green S; Hopkins L; Smaill F; Kaimal AJ; Zlatnik MG; Cheng YW; Thiet MP; Connatty E; Creedy P; Leth RA; Moller JK; Thomsen RW; Uldbierg N; Norgaard M; Lorenz RP; Botti JJ; Appelbaum PC; Bennett N; Magann EF; Dodson MK; Ray MA; Harris RL; Martin JN; Morrison JC; Mangram AJ; Horan TC; Pearson ML; Silver LC; Jarvis WR; Olsen MA; Butler AM; Willers DM; Devkota P; Gross GA; Fraser VJ; Opoien HK; Valbo A; Grinde-Andersen A; Walberg M; Owens SM; Brozanski BS; Mevn LA; Wiesenfeld HC; Schunemann HJ; Sievert DM; Ricks P; Edwards JR; Schneider A; Patel J; Srinivasan A; Smaill FM; Gyte GM; Soar J; Peyton J; Leonard M; Pullyblank AM; Souza JP; Gülmezoglu AM; Vogel J; Carroli G; Lumbiganon P; Qureshi Z; Starr RB; Zurawski J; Ismail M; Ventolini G; Neiger R; McKenna D; Wloch C; Wilson J; Lamagni T; Harrington P; Charlett A; Sheridan E; Yokoe DS; Christiansen CL; Johnson R; Sands KE; Livingston J; Shtatland ES.
| CDSR - Revisões sistemáticas Cochrane | ID: CD009516
6.

Endometrial injury in women undergoing assisted reproductive techniques / Local injury to the endometrium on the day of oocyte retrieval has a negative impact on implantation in assisted reproductive cycles: a randomized controlled trial / Endometrial local injury improves the pregnancy rate among recurrent implantation failure patients undergoing in vitro fertilisation/intra cytoplasmic sperm injection: a randomised clinical trial / Does local endometrial injury in the nontransfer cycle improve the IVF-ET outcome in the subsequent cycle in patients with previous unsuccessful IVF? A randomized controlled pilot study / The effect of local injury to the endometrium performed previously to the ovulation induction in assisted reproduction techniques: preliminary report / The effect of local injury to the endometrium for implantation and pregnancy rates in ICSI -ET cycles with recurrent implantation failure: a randomised controlled study / Endometrial Sampling (Pipelle) in IVF Patients / Impact of Local Biopsy to the Endometrium Prior to Controlled Ovarian Stimulation on Clinical Pregnancy (NIDABRECHE) / Endometrial Scratching Prior to Controlled Ovarian Stimulation (COH) in Women Undergoing In-vitro Fertilization With Previous IVF Failure (ESICOHF) / Endometrial Biopsy Protocol for In Vitro Fertilization (IVF) / Does the timing of mock embryo transfer trial improve implantation in intracytoplasmic sperm injection cycles? / Promoting implantation by local injury to the endometrium / Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization / Cytomorphometric analysis and surface ultrastructure of developing decidua / Local injury of the endometrium induces an inflammatory response that promotes successful implantation / Assisted reproductive technologies (ART) in Canada: 2006 results from the Canadian ART Register / Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist-follicle stimulating hormone ovulation induction for in-vitro fertilization / Local injury to the endometrium: its effect on implantation / Ethical issues in stopping randomized trials early because of apparent benefit / Is there a place for adjuvant therapy in IVF? / Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase / Common statistical errors in the design and analysis of subfertility trials / The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology

| CDSR - Revisões sistemáticas Cochrane | ID: CD009517
7.

Isoflavones for hypercholesterolaemia in adults / Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study / Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial / The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women / The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women / The effects of soy protein in women and men with elevated plasma lipids / Effects of isoflavones on blood lipid profiles in perimenopausal women / Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women / Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women / Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women / Efficacy on menopausal neurovegetative symptoms and some plasma lipids blood levels of an herbal product containing isoflavones and other plant extracts / Effect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass index / Isoflavone treatment for acute menopausal symptoms / Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women / Effects of soy isoflavones on endothelial function in healthy postmenopausal women / Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors / Brachial reactivity in postmenopausal women: Impact of soy isoflavone administration / The effect of soy protein isolate on bone metabolism / Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women / Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes / Benefits of soy isoflavone therapeutic regimen on menopausal symptoms / The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study / Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial / Effects of isoflavones on blood lipid profiles in perimenopausal women / Supplementation of Korean fermented soy paste doenjang reduces visceral fat in overweight subjects with mutant uncoupling protein-1 allele / Observation and analysis of the lipid-lowering effects of oat soy flour / Soy isoflavones, Mediterranean diet, and physical exercise in postmenopausal women with insulin resistance / Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: a follow-up study / Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women / Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial / Effect of isoflavone on plasma nitrite/nitrate, homocysteine, and lipid levels in Turkish women in the early postmenopausal period: a randomized controlled trial / Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy / Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women / Effect of isoflavones on lipids and bone turnover markers in menopausal women / Iron indexes and total antioxidant status in response to soy protein intake in perimenopausal women / Influence of red clover-derived isoflavones on serum lipid profile in postmenopausal women / Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones / Evidence of estrogenic effect by the three-month-intervention of isoflavone on vaginal maturation and bone metabolism in early postmenopausal women / The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status / Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods / Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause / Effects of isoflavone and exercise on BMD and fat mass in postmenopausal Japanese women: a 1-year randomized placebo-controlled trial / Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial / Effects of isoflavones on blood lipid profiles and endothelial function in postmenopausal women / Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial / Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women / Effect of pure genistein on bone markers and hot flushes / Update on lipids, inflammation and atherothrombosis / Estimated dietary flavonoid intake and major food sources of U.S. adults / Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer / National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants / Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 / Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China / Quantifying heterogeneity in a meta-analysis / Measuring inconsistency in meta-analysis / Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 / Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist / Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy / Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study / Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women / Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997 / The case of the misleading funnel plot / The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration / Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway / Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults / The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones / Equol: history, chemistry, and formation / Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan / Investigating and dealing with publication and other biases / Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials / Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: meta-analysis of randomized controlled trials / Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study / Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis / Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile / Soy isoflavone intake lowers serum LDL cholesterol: a meta-analysis of 8 randomized controlled trials in humans

Qin Yu, Niu Kai, Zeng Yuan, Liu Peng, Yi Long, Zhang Ting, Zhang Qian Yong, Zhu Jun Dong, Mi Man Tian; Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ; Aubertin-Leheudre M; Lord C; Khalil A; Dionne IJ; Dewell A; Hollenbeck CB; Bruce B; Gardner CD; Newell KA; Cherin R; Haskell WL; Mackey R; Ekangaki A; Eden JA; Wang YS; Zhang GR; Liu YJ; Zhuo HX; Xia FL; Atkinson C; Oosthuizen W; Scollen S; Loktionov A; Day NE; Bingham SA; Badeau R; Jauhiainen M; Metso J; Nikander E; Tikkanen MJ; Ylikorkala O; Blakesmith SJ; Lyons-Wall PM; George C; Joannou GE; Petocz P; Samman S; Cancellieri F; Leo V; Genazzani AD; Nappi C; Parenti GL; Polatti F; Chedraui P; San Miguel G; Hidalgo L; Morocho N; Ross S; Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM; Cianci A; Cicero AF; Colacurci N; Matarazzo MG; Leo V; Colacurci N; Chiàntera A; Fornaro F; Novellis V; Manzella D; Arciello A; Dent SB; Peterson CT; Brace LD; Swain JH; Reddy MB; Hanson KB; Fornaro F; Carotenuto V; Bisogni C; Trabucco E; Russo C; Manzella D; Gallagher JC; Satpathy R; Rafferty K; Haynatzka V; Garrido A; Maza MP; Hirsch S; Valladares L; Gonzalez S; Jayagopal V; Kilpatrick ES; Chapman T; Atkin SL; Han KK; Soares JM; Haidar MA; Lima GR; Baracat EC; Hidalgo LA; Chedraui PA; Morocho N; Ross S; San Miguel G; Ho SC; Chen YM; Ho SS; Woo JL; Jiang M; Xu YF; Miao ZL; Zhong XM; Zhang M; Liu N; Lee M; Chae S; Cha Y; Park Y; Liang SP; Zhang DP; Llaneza P; Gonzalez C; Fernandez-Iñarrea J; Alonso A; Diaz-Fernandez MJ; Arnott I; Marini H; Bitto A; Altavilla D; Burnett BP; Polito F; Stefano V; Nikander E; Tiitinen A; Laitinen K; Tikkanen M; Ylikorkala O; Oliveira LP; Jesus RP; Boulhosa RS; Mendes CM; Gnoatto MC; Lemaire DC; OzturkTurhan N; Iltemir Duvan C; Bolkan F; Onaran Y; Petri Nahas E; Nahás Neto J; Luca L; Traiman P; Pontes A; Dalben I; Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR; Schult TM; Ensrud KE; Blackwell T; Ettinger B; Wallace R; Tice JA; Swain JH; Alekel DL; Dent SB; Peterson CT; Ready MB; Terzic MM; Dotlic J; Maricic S; Mihailovic T; Tosic-Race B; Törmälä RM; Nikander E; Tiitinen A; Väisänen-Tommiska M; Ylikorkala O; Mikkola TS; Uesugi T; Toda T; Okuhira T; Chen JT; Villa P; Costantini B; Suriano R; Perri C; Macrì F; Ricciardi L; Wong JM; Kendall CW; Marchie A; Liu Z; Vidgen E; Holmes C; Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Wu J; Oka J; Tabata I; Higuchi M; Toda T; Fuku N; Wu J; Oka J; Higuchi M; Tabata I; Toda T; Fujioka M; Xiao LZ; Jiang ZP; Xu X; Huang Z; Lai SY; Hu BH; Ye YB; Wang ZL; Zhuo SY; Lu W; Liao HF; Verbruggen M; Yildiz MF; Kumru S; Godekmerdan A; Kutlu S; Albertazzi P; Steel SA; Bottazzi M; Badimon L; Storey RF; Vilahur G; Chun OK; Chung SJ; Song WO; Duncan AM; Merz-Demlow BE; Xu X; Phipps WR; Kurzer MS; Farzadfar F; Finucane MM; Danaei G; Pelizzari PM; Cowan MJ; Paciorek; Ford ES; Ajani UA; Croft JB; Critchley JA; Labarthe DR; Kottke TE; He J; Gu D; Reynolds K; Wu X; Muntner P; Zhao J; Higgins JPT; Thompson SG; Higgins JPT; Thompson SG; Deeks JJ; Altman DG; Higgins JPT; Green S (editors); Jackson RL; Greiwe JS; Schwen RJ; Kang X; Zhang Q; Wang S; Huang X; Jin S; Keinan-Boker L; Peeters PH; Mulligan AA; Navarro C; Slimani N; Mattisson I; Kreijkamp-Kaspers S; Kok L; Bots ML; Grobbee DE; Lampe JW; Schouw YT; Laatikainen T; Critchley J; Vartiainen E; Salomaa V; Ketonen M; Capewell S; Lau J; Ioannidis JPA; Terrin N; Schmid CH; Olkin I; Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JPA; Liu D; Zhen W; Yang Z; Carter JD; Si H; Reynolds KA; Liu B; Qin L; Liu A; Uchiyama S; Ueno T; Li X; Setchell KD; Brown NM; Lydeking-Olsen E; Setchell KD; Clerici C; Shimazu T; Inoue M; Sasazuki S; Iwasaki M; Sawada N; Yamaji T; Sterne JAC; Egger M; Davey Smith G; Taku K; Umegaki K; Sato Y; Taki Y; Endoh K; Watanabe S; Taku K; Umegaki K; Ishimi Y; Watanabe S; Unfer V; Casini ML; Costabile L; Mignosa M; Gerli S; Renzo GC; Weggemans RM; Trautwein EA; Zhan S; Ho SC; Zhuo XG; Melby MK; Watanabe S.
| CDSR - Revisões sistemáticas Cochrane | ID: CD009518
8.

PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer / Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma / The prognostic significance of maximum standardized uptake value of primary tumor in surgically treated non-small-cell lung cancer patients: analysis of 413 cases / Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography / Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer / Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial / Positron emission tomography may underestimate the extent of thoracic disease in lung cancer patients / Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? / The value of 18F-FDG PET/CT scan in the evaluation lymph node status in patients with non-small cell lung carcinoma / Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial / Positron emission tomography in staging early lung cancer: a randomized trial / Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT / Integrated PET/CT in the preoperative staging of lung cancer: a prospective comparison of CT, PETand integrated PET/CT / Preoperative staging of lung cancer with combined PET-CT / Diagnostic accuracy of PET/CT assigning overall TNM-stage in patients with NSCLC according to the 1997 respectively the 2010 TNM classification system / Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial / The validity of preoperative lymph node staging guidelines of European Society of Thoracic Surgeons in non-small-cell lung cancer patients / LUCIS: lung cancer imaging studies / Mediastinal staging in non-small cell lung carcinoma: CT versus F-18-FDG PET/CT / Value of dual-time-point FDG PET/CT for mediastinal nodal staging in non-small-cell lung cancer patients with lung comorbidity / Diagnostic ability of dual-time-point fdg PET/CT for mediastinal lymph node metastases in non-small cell lung cancer patients / Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer / False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer / Is there any maximum standardized uptake value variation among positron emission tomography scanners for mediastinal staging in non-small cell lung cancer? / Comparison of integrated positron emission tomography/computed tomography and mediastinoscopy in mediastinal staging of non-small cell lung cancer: analysis of 212 patients / Incremental value of PET/CT over CT for mediastinal nodal staging of non-small cell lung cancer: comparison between patients with and without idiopathic pulmonary fibrosis / Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study / Mediastinal nodal staging of nonsmall cell lung cancer using Integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients / The correlation of SUVmax with pathological characteristics of primary tumor and the value of tumor/ lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients / Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma / Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer / 18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity / Impact of parenchymal tuberculosis sequelae on mediastinal lymph node staging in patients with lung cancer / Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule / [Value of positron emission tomography-computed tomography in the diagnosis of mediastinal lymph node metastasis of non-small cell lung cancer] / Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation anddual-time-point imaging / The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax / Combined endobronchial and endoscopic ultrasound-guided fine needle aspiration for mediastinal nodal staging of lung cancer / N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT / Lymph node metastasis diagnosis using positron emission tomography with 2-[F-18] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer / A retrospective analysis of 18F-FDG PET/CT in the primary staging of non-small cell lung cancer (NSCLC) / Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer / Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer-initial results / Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer / Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer / FDG PET/CT and mediastinal nodal metastasis detection in stage T1 non-small cell lung cancer: prognostic implications / Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography / The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer / The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer / Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer / Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study / PET/CT for mediastinal lymph node staging in non-small-cell lung cancer with interstitial pneumonia / Combined use of transbronchial needle aspiration and PET/CT in mediastinal nodal staging of non small cell lung cancer / Advantages of diffusion-weighted imaging over positron emission tomography-computer tomography in assessment of hilar and mediastinal lymph nodes in lung cancer / Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers / Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer / [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non small cell lung cancer] / Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer / Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging / Accuracy of FDG-PET/CT nodal staging for non-small-cell lung cancer in surgically resectable cases: a local experience / PET/CT has enabled the development of a non invasive strategy for mediastinal staging in non small cell lung cancer (NSCLC) / Impact of NICE guidelines on mediastinal staging strategies / [The accuracy of positron emission tomography in mediastinal staging of non-small cell lung cancer] / Performance of FDG PET/CT in mediastinal nodal staging in NSCLC; comparison with chest CE-CT scan and EBUS/TBNA / Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer / Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes / Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer / Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease / Non-small cell lung cancer: dual-modality PET/CT in preoperative staging / Improved radiologic staging of lung cancer with 2-[18F]-flouro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration / The relationship between Lymph node staging and tumor SUVmax in NSCLC / Prediction of lymph node metastases in NSCLC. Three dimensional anatomical parameters do not substitute FDG-PET-CT / Objective FDG-PET analysis of mediastinal and hilar lymph nodes sampled by endobronchial ultrasound transbronchial needle aspiration / What is the shelf life of PET/CT staging of the mediastinum in non-small cell lung cancer? / Establishing a threshold SUVmax value on 18FDG-PET/CT for identifying metastatic lymph nodes in surgically resectable Non Small Cell Lung Cancer / The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers / Fusion Positron emission/Computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer / The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer / Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: aprospective study / Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer / Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study / Efficacy of convex probe endobronchial ultrasound (CP-EBUS) assisted transbronchial needle aspiration for mediastinal staging in non-small cell lung cancer cases with mediastinal lymphadenopathy / Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer / Significance of PET/CT in determining actual TNM staging for patients with various lung cancers / Impact of F18-FDG PET/CT in suspected or confirmed early stage non-small cell lung cancer / [A comparison of endobronchial ultrasound-guided transbronchial needle aspiration and integrated positron emission tomography-computed tomography in the diagnosis of malignant mediastinal/hilar lymph nodes] / Pre-treatment staging with 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): Comparative analysis of the 6th and 7th edition of the TNM classification / Analysis of risk factors for mediastinal lymph nodes metastases in non-small cell lung cancer patients with 18F-FDG PET/CT / Optimal threshold in diagnosing mediastinal lymph node metastasis of non-small cell lung cancer with maximum standardized uptake value / Does PET-CT based clinical staging of non-small cell lung cancer obviate invasive procedures? / 3D CT-Histogram analysis enables to distinguish affected and FDG-negative lymph nodes in patients with lung cancer / False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer / Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data / Is there a need for invasive mediastinal staging in centrally located non-small cell lung cancer? / [The accuracy and cost of mediastinal staging strategies for non-small cell lung cancer] / Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion / Diagnostic accuracy of preoperative intrathoracic lymph node staging on 18F-FDG PET/CT in patients with non-small cell lung cancer / [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer] / Standard uptake value of positron emission tomography in clinical stage I lung cancer: clinical application and pathological correlation / Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT / PET-CT in non-small-cell-lung cancer: Clermontoise experience / Outcomes of mediastinoscopy and surgery with or without neoadjuvant therapy in patients with non-small cell lung cancer who are N2 negative on positron emission tomography and computed tomography / A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer / Dual-time-point FDG PET/CT: Is it useful for lymph node staging in patients with non-small-cell lung cancer? / Prediction of occult lymph node metastasis in clinically N0 squamous cell lung carcinoma / Clinical value of 18F- FDG-PET/CT scan in nodal staging of patients with non small cell lung cancer. An explorative analysis of retrospective data of 401 patients / Clinical value of 18F-FDG-PET/CT scan in nodal staging of patients with non small cell lung cancer. Evaluation of retrospective data of 401 patients / Integrated FDG-PET/CT for improved T and N staging of non-small-cell lung cancer / Diagnostic value of PET/CT in preoperative staging in patients with non-small cell lung cancer / Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography / Impact of point spread function reconstruction on pre-therapeutic nodal staging with 18 F -FDG PET in non-small cell lung cancer / Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer / Measurement of primary tumor volume by PET-CT to evaluate risk of mediastinal nodal involvement in NSCLC patients with clinically negative N2 lymph nodes / Improvement in the differentiation of malignant nodes from benign nodes preoperatively in non-small cell lung cancer (NSCLC) using FDG PET/CT / Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3 / Integrated positron-emission tomography for nodal staging in lung cancer / [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer] / Mediastinal lymph nodes staging by 18F-FDG PET/CT for early-stage non-small cell lung cancer: A multicenter study / Mediastinal lymph nodes staging by 18F-FDG PET/CT for early-stage non-small cell lung cancer: A multicenter study / Mediastinal lymph nodes staging by 18F--FDG PET/CT for early stage non-small cell lung cancer: a multicenter study / [Value of endobronchial ultrasound-transbronchial needle aspiration biopsy for diagnosis of PET-CT positive mediastinal lymph nodes] / Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer / Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers / Positron emission tomography with CT in the evaluation of non-small cell lung cancer in populations with a high prevalence of tuberculosis / Differential diagnosis of mediastinal lymph node metastasis in lung cancer patients using 18F-FDG PET/CT with double quantitative SUVmax and CT value / Diagnostic value of qualitative and quantitative analysis by 18F-FDG PET/CT for mediastinal lymph nodes of lung cancer / The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer / Pre-operative radiological staging (CT and PET-CT) compared with pathological staging in patients with resected non-small cell lung cancer attending a regional thoracic centre / A comparison of CT/FDG-PET scan staging with final pathological staging in patients following lung resection / Mediastinal lymph node staging in patients with non-small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) / [The value of extra-lung lesions on ¹⁸F-FDG PET/CT in improving diagnosis of lung cancer]. / Evaluation of pulmonary nodules and lung cancer with one-inch crystal gamma coincidence positron emission tomography/CT versus dedicated positron emission tomography/CT / Accuracy of integrated PET-CT for mediastinal lymph node metastases in non-small cell lung cancer / Clinical usefulness of positron emission tomography/computed tomography and magnetic resonance imaging for lung cancer / The consensus to evaluate mediastinal lymph node metastasis in primary lung cancer with integrated FDG PET/CT / Fluorodeoxyglucose positron emission tomography integrated with computed tomography to determine resectability of primary lung cancer / Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results / STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients / How efficient is PET/CT in metabolic characterization of lung lesions? / The role of tumor SUVmax/lymph node SUVmax ratio viewed on PET-CT in the detection of mediastinal metastasis in patients with lung cancer / Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer / Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer / Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer / [Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients] / Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection / PET/CT staging of T1-stage non-small cell lung cancer / [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)] / Lymph-node mediastinal staging in patients with NSCLC: 18-FDG PET-TC versus TC MDC / Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer / Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study / Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging / Positron-emission tomography for lung cancer in a tuberculosis-endemic region / Mediastinoscopy and F-18 PET-CT in NSCLC / Is Mediastinoscopy Still the Gold Standard to Evaluate Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma? / Outcome of PET/CT imaging in staging of non-small-cell lung cancer <= 3cm in diameter / Pattern and predictors of false positive lymph node involvement on positron emission tomography in patients with non-small cell lung Cancer / Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection / Integrated PET/CT in non-small cell lung cancer staging--clinical and pathological agreement / Detection of nodal metastatic disease in patients with non-small cell lung cancer: comparison of positron emission tomography (PET), contrast-enhanced computed tomography (CT), and combined PET-CT / [Application of ¹⁸F-FDG PET/CT in pulmonary disease: a report of 419 cases] / Preoperative staging of non-small-cell lung cancer: Comparison of whole body diffusion weighted magnetic resonance imaging and 18f-fluorodeoxyglucose positron emission tomography/computed tomography / Preoperative lymph node staging in patients of non-small-cell lung cancer: accuracy of 18F-FDG PET/CT / Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer / Preoperative nodal staging in patients with non-small cell lung cancer: Comparison between multimodality MR imaging plus PET/CT and PET/CT alone / Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: Comparisons of clinical effectiveness in a randomized trial / 18FDG PET/CT in diagnosis and metastasis detection of lung neoplasms / [Comparing serum tumor antigen detection combined with CT scan with PET-CT for lung cancer diagnosis] / [Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax] / [The advantage of positron emission tomography combined with computer tomography (PET-CT) in the diagnosis of lung cancer, experience with 408 patients] / Contribution of 18F-FDG PET/CT in the management of patients with lung cancer / Preoperative mediastinal staging of NSCLC: the clinical impact of 18F-FDG PET/CT / The variation of prognostic significance of maximum standarized uptake value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected non-small cell lung carcinoma / Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial / Comparison of primary tumor maximal standardized uptake value (SUVmax) on preoperative [18F]fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and histological subtype in patients with non-small cell lung cancer (NSCLC) / Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer / Improving Outcomes: a strategy for cancer / Invasive mediastinal staging of lung cancer / A unification of models for meta-analysis of diagnostic accuracy studies / Determination of the prognostic value of [18F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer / Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT -- a prospective study / Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer / Repeatability of the Maximum Standard Uptake Value (SUVmax) in FDG PET / A correlation study between maximum standardized uptake values and pathology and clinical staging in nonsmall cell lung cancer / Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis / Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR / Surgery for local and locally advanced non-small cell lung cancer / Referral guidelines for suspected cancer / The diagnosis and treatment of lung cancer (update) / Concurrent chemoradiotherapy in non-small cell lung cancer / Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews / Review Manager (RevMan) / A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations / Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging / Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines / Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study / QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies / Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer

Schmidt-Hansen Mia, Baldwin David R, Hasler Elise, Zamora Javier, Abraira Víctor, Roqué i Figuls Marta; Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Bryant AS; Cerfolio RJ; Klemm KM; Ojha B; Cerfolio RJ; Bryant AS; Ojha B; Eloubeidi M; Carnochan FM; Walker WS; Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Czepczynski R; Zielinski P; Stangierski A; Gabryel P; Kasprzak W; Dyszkiewicz W; Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Maziak DE; Darling GE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Wever W; Ceyssens S; Mortelmans L; Stroobants S; Marchal G; Bogaert J; El-Hariri MA; Gouhar GK; Refat AM; Fischer B; Lassen U; Mortensen J; Larsen S; Loft A; Bertelsen A; Fischer BM; Loft A; Bertelsen AK; Mortensen J; Lassen U; Fischer BM; Mortensen J; Hansen H; Vilmann P; Larsen SS; Loft A; Gunluoglu MZ; Melek H; Medetoglu B; Demir A; Kara HV; Dincer SI; Harders SW; Harders; SW; Madsen HH; Hjorthaug K; Arveschoug AK; Rasmussen TR; Meldgaard; P; Hu M; Han A; Xing L; Yang W; Fu Z; Huang C; Hu M; Yu J; Xing L; Han A; Kong L; Hwangbo B; Kim SK; Lee HS; Lee HS; Kim MS; Lee JM; Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Iskender I; Kadioglu SZ; Kosar A; Atasalihi A; Kir A; Iskender I; Kapicibasi HO; Kadioglu SZ; Sevilgen G; Tezel C; Kosar A; Jeon TY; Lee KS; Yi CA; Chung MP; Kwon OJ; Kim B-T; Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Kim YK; Lee KS; Kim BT; Choi JY; Kim H; Kwon OJ; Koksal D; Demirag F; Bayiz H; Ozmen O; Tatci E; Berktas B; Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Lee BE; Haag D; Lown T; Lau D; Calhoun R; Follette D; Lee JW; Kim BS; Lee DS; Chung JK; Lee MC; Kim S; Lee SH; Min JW; Lee CH; Park CM; Goo JM; Chung DH; Lee SM; Park CM; Paeng JC; Im HJ; Goo JM; Lee HJ; Li XD; Yin JL; Liu WK; Ouyang X; Zhou Z; Qiao GB; Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Morikawa M; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Ohnishi R; Yasuda I; Kato T; Tanaka T; Kaneko Y; Suzuki T; Ohno Y; Koyama H; Yoshikawa T; Nishio M; Aoyama N; Onishi Y; Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M; Ozkan EA; Araz M; Soydal C; Aras G; Perigaud C; Bridji B; Roussel JC; Sagan C; Mugniot A; Duveau D; Plathow C; Aschoff P; Lichy MP; Eschmann S; Hehr T; Brink I; Sanli M; Isik AF; Zincirkeser S; Elbek O; Mete A; Tuncozgur B; Saydam O; Gokce M; Kilicgun A; Tanriverdi O; Shin KM; Lee KS; Shim YM; Kim J; Kim BT; Kwon OJ; Sommer G; Wiese M; Winter L; Lenz C; Klarhofer M; Forrer F; Subedi N; Scarsbrook A; Darby M; Korde K; Mc SP; Muers MF; Tasci E; Tezel C; Orki A; Akin O; Falay O; Kutlu CA; Toba H; Kondo K; Otsuka H; Takizawa H; Kenzaki K; Sakiyama S; Tournoy KG; Maddens S; Gosselin R; Maele G; Meerbeeck JP; Kelles A; Uruga H; Üskül BT; Baysungur V; Aksoy F; Turan FE; Sevilgen G; Turker H; Usuda K; Sagawa M; Motono N; Ueno M; Tanaka M; Machida Y; Usuda K; Zhao XT; Sagawa M; Matoba M; Kuginuki Y; Taniguchi M; Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Yang WF; Tan GZ; Fu Z; Yu JM; Yang W; Zhang Y; Fu Z; Yu J; Sun X; Mu D; Yi CA; Shin; KM; Lee KS; Kim BT; Kim H; Agraval J; Ahmed I; Stuart R; Muller M; Stamenkovic S; Ahmed IM; Stuart R; Stamenkovic S; Akpinar D; Ceylan KC; Duman E; Unsal S; Kaya SO; Al-Ibraheem A; Allen-Auerbach M; Yeom K; Park J; Phelps M; Czernin J; Al-Sarraf N; Gately K; Lucey J; Wilson L; McGovern E; Young V; Al-Sarraf N; Gately K; Lucey J; Wilson L; McGovern E; Young V; An YS; Sun JS; Park KJ; Hwang SC; Park KJ; Sheen SS; Antoch G; Stattaus J; Nemat AT; Marnitz S; Beyer T; Kuehl H; Aquino SL; Asmuth JC; Alpert NM; Halpern EF; Fischman AJ; BalciI TA; Beyer F; Buerke B; Gerss J; Scheffe K; Puesken M; Weckesser M; Bhatt MK; Booth K; Hanna G; McGonigle N; McGuigan J; McManus K; O&#8217;Sullivan J; Boulougouri K; Bryant AS; Cerfolio RJ; Carrillo SA; Daniel; VC; Hall N; Hitchcock CL; Ross P; Kassis ES; Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA; Cerfolio; RJ; Bryant AS; Eloubeidi MA; Cerfolio RJ; Bryant AS; Cerfolio RJ; Bryant AS; Cetinkaya E; Seyhan EC; Ozgul A; Gencoglu A; Ozgul G; Cam E; Kamiloglu E; Ceylan N; Do&#287;an S; Kocaçelebi K; Sava&#351; R; Çakan A; Ça&#287;rici U; Chiba K; Isoda M; Chiba M; Kanematsu T; Eguchi S; Colville D; Cömert SS; Caglayan B; Fidan A; Salepci B; Dogan C; Demirhan R; Ece D; Delgado-Bolton RC; Duan X-B; Duan X-B; Faber DL; Kremer R; Orlovsky M; Lapidot M; Guralnik L; Kagna O; Flechsig P; Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Gregory DL; Hicks RJ; Hogg A; Binns DS; Shum PL; Milner A; Günlüo&#287;lu MZ; Melek H; Turna A; Medeto&#287;lu B; Kara HV; Demir A; Günlüo&#287;lu; MZ; Melek H; Demir A; Medeto&#287;lu B; Kara HV; Dinçer S&#304;; Halpern BS; Schiepers C; Weber WA; Crawford TL; Fueger BJ; Phelps ME; Hong SP; Song HC; Chong A; Oh JR; Kim JH; Yoo SU; Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Huang TW; Hsieh CM; Chang H; Cheng YL; Tzao C; Huang WS; Kasai T; Motoori K; Horikoshi T; Uchiyama K; Yasufuku K; Takiguchi Y; Kelly A; Cachin F; Freitas D; Geissler B; Bapt A; Karidioula I; Kim HK; Choi YS; Kim K; Shim YM; Park K; Ahn YC; Kim YN; Yi CA; Lee KS; Kwon O; Lee HY; Kim BT; Kim DW; Kim WH; Kim CG; Kim D; Song B; Hong C; Lee S; Ahn B; Lee J; Kommata S; Kommata S; Krueger S; Buck A; Pauls S; Halter G; Schumann C; Kropf C; Lapinska GE; Fijolek-Warszewska A; Bryszewska M; Kozlowicz-Gudzinska I; Glogowski M; Zmijewski M; Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; Lasnon C; Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Lebioda A; Makarewicz R; Malkowski B; Dancewicz M; Kowalewski J; Windorbska W; Lee EJ; Choi JY; Choi Y; Choe YS; Lee KH; Lee KS; Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Lee HJ; Kim YT; Kang WJ; Lee HJ; Kang CH; Kim JH; Li M; Wu N; Liang Y; Zheng R; Liu Y; Zhang WJ; Li X; Li X; Li X; Zhang H; Xing L; Ma H; Xie P; Zhang L; Li SB; He JX; Li SY; Chen HZ; Yin WQ; Cheng XL; Lin WY; Hsu WH; Lin KH; Wang SJ; Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Low SY; Eng P; Keng GH; Ng DC; Ma W; Xu W; Zhu X; Dai D; Song X; Zhu L; Ma W; Xu W; Zhu X; Wang J; Dai D; Song X; Maeda R; Isowa N; Onuma H; Miura H; Harada T; Touge H; Mariam J; Peng C; Clarke J; Thompson JC; Meduoye A; Black E; Duffy J; Beggs D; Majewski A; Mendez M; Maximiano C; Huelves M; Doger de Speville DG; Ibeas P; Ruiz-Valdepeñas A; Mi B; Wan W; Yu C; You X; Jiang F; You Q; Moodie K; Cherk MH; Lau E; Turlakow A; Skinner S; Hicks R; Moreno Garcia V; Castro JD; Feliu J; Belda C; Barriuso J; Marin MD; Morikawa M; Nakajima E; Sakata Y; Saji H; Kato Y; Suga Y; Uchino Y; Nakamura H; Taguchi M; Kitamura H; Nishikawa J; Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ozkan ZG; Özta&#351; S; Öztürk AV; Acartürk E; Tezel Y; Özdemir M; Ataç G; Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Pfannenberg AC; Aschoff P; Brechtel K; Müller M; Bares R; Paulsen F; Pozo-Rodriguez F; Martin de Nicolás JL; Sánchez-Nistal MA; Maldonado A; Garcia de Barajas S; Calero-Garcia R; Prévost A; Papathanassiou D; Jovenin N; Menéroux B; Cuif-Job A; Bruna-Muraille C; Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Salman KA; Steinmann CH; Sukumar VP; Schulthess GK; Steinert HC; Sánchez Sánchez R; Rodríguez Fernández A; Gómez Río M; Alkurdi Martínez A; Castellón Rubioc VE; Ramos Font C; Schiavariello S; Schreyögg J; Weller J; Stargardt T; Herrmann K; Bluemel C; Dechow T; Schwenzer NF; Schraml C; Mueller M; Brendle C; Sauter A; Spengler W; Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Sit AK; Sihoe AD; Suen WS; Cheng LC; Sivrikoz MC; Sivrikoz C; Ak I; Simsek FS; Döner E; Dündar E; Steinert H; Tamura; M; Oda M; Matsumoto I; Waseda R; Watanabe G; Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Vaz AP; Fernandes G; Souto Moura C; Bastos P; Queiroga H; Hespanhol V; Ventura E; Islam T; Gee MS; Mahmood U; Braschi M; Harisinghani MG; Wang F; Ma S; Shen L; Li N; Yang Z; Chen K; Wiese MN; Wu CS; Yi CA; Lee KS; Kim BT; Shim SS; Chung MJ; Sung YM; Yi CA; Lee KS; Kim YN; Lee E; Kwon OJ; Kim BT; Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Yu L-J; Duan Y; Liang X-Y; Wang X; Zhang X; Li TR; Chen ZS; Ouyang XN; Zhang TM; Zhang LM; Liu Y; Zhang ZF; Wang CL; Zsiray M; Markoczy Z; Magyar M; Lengyel Z; Fekeshazy A; Borbely L; Zsiray M; Markoczy Z; Lengyel Z; Fekeshazy A; Kasler M; Borbely K; Zsiray M; Casali C; Cucca M; Rossi G; Barbieri F; Iacuzio L; Bagni B; Cerfolio RJ; Bryant AS; Ojha B; Eloubeidi M; Davidson JA; Wong V; Fraser R; Hirsch V; Leyn P; Dooms C; Kuzdzal J; Lardinois D; Passlick B; Rami-Porta R; Detterbeck FC; Jantz MA; Wallace M; Vansteenkiste J; Silvestri GA; Harbord RM; Deeks JJ; Egger M; Whiting P; Sterne JA; Jeong HJ; Min JJ; Park JM; Chung JK; Kim BT; Jeong JM; Kim B-T; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Lee BE; Haag D; Lown T; Lau D; Calhoun R; Follette D; Lindholm H; Staaf J; Jacobsson H; Brolin F; Hatherly R; Sânchez-Crespo A; Lu P; Yu L; Li Y; Sun Y; Macaskill P; Maemondo M; Inoue A; Kobayashi K; Sugawara S; Oizumi S; Isobe H; Manser R; Wright G; Hart D; Byrnes G; Campbell D; Wainer Z; O'Rourke N; Roqué i Figuls M; Farré Bernadó N; Macbeth F; Reitsma JB; Glas AS; Rutjes AW; Scholten RJ; Bossuyt PM; Zwinderman AH; Rutter CM; Gatsonis CA; Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Silvestri GA; Gonzalez AV; Jantz MA; Margolis ML; Gould MK; Tanoue LT; Tournoy KG; Maddens S; Gosselin R; Maele G; Meerbeeck JP; Kelles A; Whiting PF; Rutjes AWS; Westwood ME; Mallett S; Deeks JJ; Reitsma JB; Yi CA; Lee KS; Kim BT; Shim SS; Chung MJ; Sung YM.
| CDSR - Revisões sistemáticas Cochrane | ID: CD009519
9.

Home- or community-based programmes for treating malaria / Using community health workers for malaria control: experience in Zaire / Effectiveness of a community intervention on malaria in rural Tanzania - a randomised controlled trial / The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial / Teaching mothers to provide home treatment of malaria in Tigray, Ethiopia: a randomised trial / Process and effects of a community intervention on malaria in rural Burkina Faso: randomized controlled trial / Malaria rapid testing by community health workers Is effective and safe for targeting malaria treatment: randomised cross-over trial in Tanzania / Home-based management of fever and malaria treatment practices in Uganda / Community-based malaria control in Saradidi, Kenya: description of the programme and impact on parasitaemia rates and antimalarial antibodies / Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial / Community case management of fever Due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial / Evaluating different dimensions of programme effectiveness for private medicine retailer malaria control interventions in Kenya / Effectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control / Assessment of a treatment guideline to improve home management of malaria in children in rural south-west Nigeria / An assessment of accuracy of mothers' presumptive diagnosis of fever at home in southwest Nigeria: evidence for switch to parasite-based diagnostic test / Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites / Rapid testing for malaria in settings where microscopy is available and peripheral clinics where only presumptive treatment is available: a randomised controlled trial in Ghana / Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana / Health centre versus home presumptive diagnosis of malaria in southern Ghana: implications for home-based care policy / Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test / Comparison of two strategies for control of malaria within a primary health care programme in the Gambia / The role of voluntary village aides in the control of malaria by presumptive treatment of fever. 2. Impact on village health / Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study / A community-based programme to provide prompt and adequate treatment of presumptive malaria in children / The effect of community nurses and health volunteers on child mortality: the Navrongo Community Health and Family Planning Project / A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia / Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso / Effect of malaria rapid diagnostic tests on the management of uncomplicated malaria with artemether-lumefantrine in Kenya: a cluster randomized trial / Implementation of home based management of malaria in children reduces the work load for peripheral health facilities in a rural district of Burkina Faso / Exploring dimensions of access to medical care / Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana / The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya / GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables / Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence / Knowledge, beliefs, and practices in relation to malaria transmission and vector control in Guatemala / Treatment-seeking behaviour for malaria in children under five years of age: implication for home management in rural areas with high seasonal transmission in Sudan / Treatment seeking for malaria: a review of recent research / Chemoprophylaxis and intermittent treatment for preventing malaria in children / Defining equity in physical access to clinical services using geographical information systems as part of malaria planning and monitoring in Kenya / Access to health care in contexts of livelihood insecurity: a framework for analysis and action / Review Manager (RevMan) / Treatment of childhood fevers and other illnesses in three rural Nigerian communities / Artemisinin-based combination therapy for treating uncomplicated malaria / The global distribution of clinical episodes of Plasmodium falciparum malaria / Home management of malaria - Authors' reply / Access to malaria treatment in young children of rural Burkina Faso / Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities / Scaling up home-based management of malaria: from research to implementation / WHO briefing on malaria treatment guidelines and artemisinin monotherapies / World Malaria Report 2008 / World Malaria Report 2009 / Guidelines for the treatment of malaria / Antimalarial drug utilization by women in Ethiopia: a knowledge-attitudes-practice study

Okwundu Charles I, Nagpal Sukrti, Musekiwa Alfred, Sinclair David; Delacollette C; Van der Stuyft P; Molima K; Eriksen J; Mujinja P; Warsame M; Nsimba S; Kouyate B; Gustafsson LL; Kangwana BP; Kedenge SV; Noor AM; Alegana VA; Nyandigisi AJ; Pandit J; Kidane G; Morrow RH; Kouyaté B; Somé F; Jahn A; Coulibaly B; Eriksen J; Sauerborn R; Mubi M; Janson A; Warsame M; Mårtensson A; Källander K; Petzold MG; Nsungwa-Sabiiti J; Peterson S; Pariyo G; Ogwal-Okeng J; Petzold MG; Tomson G; Spencer HC; Kaseje DC; Collins WE; Shehata MG; Turner A; Stanfill PS; Staedke SG; Mwebaza N; Kamya MR; Clark TD; Dorsey G; Rosenthal PJ; Yeboah-Antwi K; Pilingana P; Macleod WB; Semrau K; Siazeele K; Kalesha P; et al; Abuya TO; Fegan G; Amin AA; Akhwale WS; Noor AM; Snow RW; et al; Ahorlu CK; Koram KA; Seakey AK; Weiss MG; Ajayi IO; Falade CO; Bamgboye EA; Oduola AM; Kale OO; Ajayi IO; Falade CO; Kale OO; Ajayi IO; Browne EN; Garshong B; Bateganya F; Yusuf B; Agyei-Baffour P; Ansah EK; Narh-Bana S; Epokor M; Akanpigbiam S; Quartey AA; Gyapong J; Chinbuah AM; Gyapong JO; Pagnoni F; Wellington EK; Gyapong M; Dunyo SK; Afari EA; Koram KA; Ahorlu CK; Abubakar I; Nkrumah FK; Elmardi KA; Malik EM; Abdelgadir T; Ali SH; Elsyed AH; Mudather MA; Greenwood BM; Greenwood AM; Bradley AK; Snow RW; Byass P; Hayes RJ; et al; Moir JS; Tulloch JL; Vrbova H; Jolley DJ; Heywood PF; Alpers MP; Ngasala BE; Malmberg M; Carlsson AM; Ferreira PE; Petzold MG; Blessborn D; Pagnoni F; Convelbo N; Tiendrebeogo J; Cousens S; Esposito F; Pence BW; Nyarko P; Phillips JF; Debpuur C; Sesay S; Milligan P; Touray E; Sowe M; Webb EL; Greenwood BM; Sirima SB; Konaté A; Tiono AB; Convelbo N; Cousens S; Pagnoni F; Skarbinski J; Ouma PO; Causer LM; Kariuki SK; Barnwell JW; Alaii JA; Tiono AB; Kaboré Y; Traoré A; Convelbo N; Pagnoni F; Sirima SB; Andersen RM; McCutcheon A; Aday LA; Chiu GY; Bell R; Chandramohan D; Owusu-Agyei S; Carneiro I; Awine T; Amponsa-Achiano K; Mensah M; Gitonga CW; Amin AA; Ajanga A; Kangwana BB; Noor AM; Snow RW; Guyatt G; Oxman AD; Akl EA; Kunz R; Vist G; Brozek J; Higgins JPT; Green S (editors); Hopkins H; Talisuna A; Whitty CJ; Staedke SG; Klein RE; Weller SC; Zeissig R; Richards FO; Ruebush TK; Malik EM; Hanafi K; Ali SH; Ahmed ES; Mohamed KA; McCombie SC; McIntyre D; Mooney G (editors); Meremikwu MM; Donegan S; Esu E; Noor AM; Zurovac D; Hay SI; Ochola SA; Snow RW; Obrist B; Iteba N; Lengeler C; Makemba A; Mshana C; Nathan R; et al; Salako LA; Brieger WR; Afolabi BM; Umeh RE; Agomo PU; Asa S; Sinclair D; Zani B; Donegan S; Olliaro P; Garner P; Snow RW; Guerra CA; Noor AM; Myint HY; Hay SI; Staedke SG; Mwebaza N; Kamya MR; Rosenthal PJ; Whitty CJM; Tipke M; Louis VR; Yé M; De Allegri M; Beiersmann C; Sié A; et al; Whitty CJM; Chandler C; Ansah E; Leslie T; Staedke SG; Yeneneh H; Gyorkos TW; Joseph L; Pickering J; Tedla S.
| CDSR - Revisões sistemáticas Cochrane | ID: CD009527
10.

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis / Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection / Clinical evidence for combination antibiotic susceptibility testing (synergy testing) [abstract] / Treatment of CF exacerbations based on multiple combination antibiotic susceptibility testing-a randomized, double-blind, controlled clinical trial [abstract] / Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial / Antibiotic susceptibility in Pseudomonas Aeruginosa (PA) isolates following repeated exposure to aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis [abstract] / Effect of repeated exposure to aztreonam for inhalation solution (AZLI) therapy on cystic fibrosis respiratory pathogens [abstract] / Effect of multiple courses of Aztreonam Lysine for inhalation (AZLI) on FEV1 and weight in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA): analysis of 18 month data from CP-AI-006 [abstract] / Adherence over multiple courses of Aztreonam for inhalation (AZLI): effect on disease-related endpoints in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA) [abstract] / An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis / Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients / Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis / The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms / Statistical methods for the meta-analysis of cluster randomized trials / Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation / Meta-analyses involving cross-over trials: methodological issues / Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing / Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment / Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group / Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis / Pathophysiology and management of pulmonary infections in cystic fibrosis / Is there value in susceptibility testing of Pseudomonas aeruginosa causing chronic infection in patients with cystic fibrosis? / Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis / Measuring inconsistency in meta-analyses / Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1 [updated March 2011] / Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1 [updated March 2011] / Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung / Antimicrobial susceptibility testing: a review of general principles and contemporary practices / Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition / Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients / Clinical implications of antimicrobial resistance for therapy / Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis / Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection / Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients / Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis / Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints / Biofilms, antimicrobial resistance, and airway infection / Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection / Management of pulmonary disease in patients with cystic fibrosis / Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms / Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis / Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1 [updated March 2011] / Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? / Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa / Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients / Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis

Waters Valerie, Ratjen Felix; Moskowitz SM; Emerson JC; McNamara S; Shell RD; Orenstein DM; Rosenbluth D; Aaron S; Aaron S; Vandemheen K; Ferris W; Tullis E; Haase D; Berthiaume Y; Aaron SD; Vandemheen KL; Ferris W; Fergusson D; Tullis E; Haase D; Oermann CM; McCoy KS; Retsch-Bogart GZ; Gibson R; McKevitt M; Montgomery B; Oermann CM; McCoy KS; Retsch-Bogart GZ; Gibson R; McKevitt M; Montgomery B; Oermann CM; McCoy KS; Retsch-Bogart GZ; Gibson RL; Montgomery AB; Oermann CM; McCoy KS; Retsch-Bogart GZ; Gibson RL; Quittner AL; Montgomery AB; Oermann CM; Retsch-Bogart GZ; Quittner AL; Gibson RL; McCoy KS; Montgomery AB; Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Ceri H; Olson ME; Stremick C; Read RR; Morck D; Buret A; Donner A; Piaggio G; Villar J; Drenkard E; Ausubel FM; Elbourne DR; Altman DG; Higgins JPT; Curtin F; Worthington HV; Vail A; Foweraker JE; Laughton CR; Brown DF; Bilton D; Frederiksen B; Lanng S; Koch C; Hoiby N; Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Gee L; Abbott J; Conway S; Etherington C; Webb A; Gibson RL; Burns JL; Gilligan PH; Henry RL; Mellis CM; Petrovic L; Higgins JPT; Thompson SG; Deeks JJ; Altman DG; Higgins JPT; Altman DG; Deeks JJ; Higgins JPT; Altman DG; Hogardt M; Heesemann J; Jorgensen JH; Ferraro MJ; Kosorok MR; Zeng L; West SE; Rock MJ; Splaingard ML; Laxova A; Lee TW; Brownlee KG; Conway SP; Denton M; Littlewood JM; MacGowan AP; Moskowitz SM; Foster JM; Emerson J; Burns JL; Moskowitz SM; Foster JM; Emerson JC; Gibson RL; Burns JL; Murray TS; Egan M; Kazmierczak BI; Pamukcu A; Bush A; Buchdahl R; Parmar MK; Torri V; Stewart L; Prince AS; Quittner AL; Modi AC; Wainwright C; Otto K; Kirihara J; Montgomery AB; Ramsey BW; Singh PK; Schaefer AL; Parsek MR; Moninger TO; Welsh MJ; Greenberg EP; Smith AL; Fiel SB; Mayer-Hamblett N; Ramsey B; Burns JL; Sterne JAC; Egger M; Stressmann FA; Rogers GB; Marsh P; Lilley AK; Daniels TW; Carroll MP; Schobert M; Tielen P; Wagner T; Soong G; Sokol S; Saiman L; Prince A; Waters V; Ratjen F.
| CDSR - Revisões sistemáticas Cochrane | ID: CD009528
Resultados 1 - 10 de 6.250